Related Experiment Video
Updated: Apr 4, 2026

12:47
Tangential Flow Ultrafiltration: A “Green” Method for the Size Selection and Concentration of Colloidal Silver Nanoparticles
Published on: October 4, 2012
18.6K
Crystalline Silver Nanoparticles by Using Polygala tenuifolia Root Extract as a Green Reducing Agent
Journal of Nanoscience and Nanotechnology
|September 11, 2015
Summary
Researchers synthesized silver nanoparticles (AgNPs) using Polygala tenuifolia root extract, creating an eco-friendly antibacterial agent. This green synthesis method offers a cost-effective and biocompatible alternative for combating multidrug-resistant bacteria.
Area of Science:
- Nanotechnology
- Materials Science
- Microbiology
Background:
- Multidrug-resistant bacteria pose a significant global health threat.
- Conventional chemical synthesis of silver nanoparticles (AgNPs) involves toxic chemicals, limiting biomedical applications.
- There is a need for eco-friendly and biocompatible methods for AgNP synthesis.
Purpose of the Study:
- To synthesize silver nanoparticles (AgNPs) using an eco-friendly approach.
- To characterize the synthesized AgNPs.
- To evaluate the antibacterial activity of AgNPs against various bacteria.
Main Methods:
- Green synthesis of AgNPs using 70% aqueous ethanol extract of Polygala tenuifolia root.
- Characterization using UV-Visible spectrophotometry, HR-TEM, AFM, XRD, and FTIR.
- Antibacterial activity testing against Gram-positive and Gram-negative bacteria.
Main Results:
- AgNPs exhibited a surface plasmon resonance band at 414 nm.
- HR-TEM and AFM confirmed spherical and irregular AgNP shapes with an average diameter of approximately 15-18 nm.
- XRD confirmed the crystalline structure of AgNPs.
- AgNPs demonstrated significant antibacterial activity, particularly against Escherichia coli.
Conclusions:
- Polygala tenuifolia root extract can be effectively used for the green synthesis of AgNPs.
- The synthesized AgNPs are biocompatible, cost-effective, and scalable.
- This method provides a promising alternative for developing AgNP-based antibacterial agents to combat drug-resistant infections.

